when will tirzepatide get fda approval What Is Used for? Approved and Potential Uses when will tirzepatide get fda

JAMA, 2024

Originally approved by the FDA for the treatment of adult obesity in 2014, the drug received authorisation in 2020 for obesity in adolescents aged 12-17 years old (Mller, Blher, Tschp, DiMarchi)

This growing popularity has at the same time, given rise to online discussions and trends that can misrepresent safe and effective medication use

Where mood changes are linked to Mounjaro (most often anxiety related to GI symptoms or appetite changes in the first few weeks, or after a dose increase), they typically ease as your body adjusts, generally within a few weeks

Increasing fibre gradually helps to avoid excessive bloating and allows the gastrointestinal tract to adapt

Eating fiber, drinking water, and staying active work better than taking enzymes